Chimeric antigen receptor (car)-modified immune effector cell therapy for acute myeloid leukemia (aml)

HIGHLIGHTS

• who: Utkarsh H. Acharya and Roland B. Walter from the Divisions of Hematologic Malignancies and Immune Effector Cell Therapy, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA Department of Medicine, Division of Hematology, University of Washington, Seattle, WA, USA have published the paper: Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML), in the Journal: Cancers 2020, 2020, 12, 12, 3617 x FOR PEER REVIEW Cancers of /2020/
• what: An updated analysis of this trial has reported MRD-negative responses in seven of nine treated AML patients . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.